Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |